Live Crown Castle Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

NewAmsterdam Pharma Co N.V.

NAMS NAMSW

Latest SEC Filings from NewAmsterdam Pharma Co N.V.

  1. 1
    1

    NewAmsterdam Pharma Reports 81% Revenue Decline and $64.1 Million Net Loss in Q2 2026

    via official filing (AI summary) 3 months ago 0 comments
  2. 2
    1

    NewAmsterdam Pharma Reports Q1 2026 Financial Results with $3.0M Revenue

    via official filing (AI summary) 6 months ago 0 comments
  3. 3
    1

    NewAmsterdam Pharma Reports $203.8 Million Net Loss and 50.6% Revenue Decrease for 2025

    via official filing (AI summary) 8 months ago 0 comments
  4. 4
    1

    NewAmsterdam Pharma Reports 99% Revenue Decline and Increased Operating Losses in Q3 2025

    via official filing (AI summary) 12 months ago 0 comments
  5. 5
    1

    NewAmsterdam Pharma Reports 740% Revenue Growth to $19.1 Million in Q2 2025

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    NewAmsterdam Pharma Reports 113% Revenue Growth to $2.98 Million in Q1 2025

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    NewAmsterdam Pharma Reports 890% Revenue Growth, Improved Operating Loss in Latest Quarter

    via official filing (AI summary) almost 2 years ago 0 comments